Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

Summary

Interleukin-2 may stimulate a person's white blood cells to kill tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining bryostatin 1 with interleukin-2 may cause a stronger immune response and kill more tumor cells. Randomized phase II trial to study the effectiveness of combining interleukin-2 and bryostatin 1 in treating patients who have advanced kidney cancer

Timeline

Start

2002-01

Primary completion

2006-06

Completion

—

Drugs

Indications